Prevention of carcinogenesis and inhibition of breast cancer tumor burden by dietary stearate.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Carcinogenesis

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgr092PMID 21586513PMCID PMC3149204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stearate Preferentially Induces Apoptosis in Human Breast Cancer Cells

  2009cited by this paper
• Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion

  2009cited by this paper
• Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice

  2009cited by this paper
• Ral GTPases and cancer: linchpin support of the tumorigenic platform

  2008cited by this paper
• Fat intake and breast cancer revisited.

  2007cited by this paper
• Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China.

  2007cited by this paper
• Protein kinase C and other diacylglycerol effectors in cancer

  2007cited by this paper
• Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer.

  2005cited by this paper
• RhoC Induces Differential Expression of Genes Involved in Invasion and Metastasis in MCF10A Breast Cells

  2004cited by this paper
• Biomarkers of dietary fatty acid intake and the risk of breast cancer: A meta‐analysis

  2004cited by this paper
• The Ras Signaling Pathway in Mammary Tumorigenesis and Metastasis

  2004cited by this paper
• Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells

  2004cited by this paper
• No relations between breast cancer risk and fatty acids of erythrocyte membranes in postmenopausal women of the Malmö Diet Cancer cohort (Sweden)

  2004cited by this paper
• Oncogenic Ras Leads to Rho Activation by Activating the Mitogen-activated Protein Kinase Pathway and Decreasing Rho-GTPase-activating Protein Activity*

  2003cited by this paper
• Up-Regulation of Small GTPases, RhoA and RhoC, Is Associated with Tumor Progression in Ovarian Carcinoma

  2003cited by this paper
• Saturated Fatty Acid-induced Apoptosis in MDA-MB-231 Breast Cancer Cells

  2003cited by this paper
• Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature

  2003cited by this paper
• Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.

  2003cited by this paper
• Ras promotes p21Waf1/Cip1 protein stability via a cyclin D1‐imposed block in proteasome‐mediated degradation

  2003cited by this paper
• Palmitic and stearic fatty acids induce caspase‐dependent and ‐independent cell death in nerve growth factor differentiated PC12 cells

  2003cited by this paper
• Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.

  2002cited by this paper
• EGFR-mediated cell cycle regulation.

  2002cited by this paper
• Saturated FFAs, palmitic acid and stearic acid, induce apoptosis in human granulosa cells.

  2001cited by this paper
• Cross‐talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility

  2001cited by this paper
• Estrogen suppression of EGFR expression in breast cancer cells: A possible mechanism to modulate growth *

  2001cited by this paper
• Ras and Rho regulation of the cell cycle and oncogenesis.

  2001cited by this paper
• Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour

  2001cited by this paper
• Small GTP-binding proteins.

  2001cited by this paper
• Genomic analysis of metastasis reveals an essential role for RhoC

  2000cited by this paper
• Insulin Resistance: the Metabolic Syndrome X

  2000cited by this paper
• Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression*

  1999cited by this paper
• Rho GTPases are over‐expressed in human tumors

  1999cited by this paper
• The Pathophysiological Consequences of Adipose Tissue Insulin Resistance

  1999cited by this paper
• A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

  1999cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.

  1998cited by this paper
• Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1

  1998cited by this paper
• Cell cycle progression: new therapeutic target for vascular proliferative disease.

  1998cited by this paper
• Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation

  1997cited by this paper
• Cyclin E-CDK2 is a regulator of p27Kip1.

  1997cited by this paper
• Phosphorylation‐dependent degradation of the cyclin‐dependent kinase inhibitor p27Kip1

  1997cited by this paper
• Fatty acids and breast cancer cell proliferation.

  1997cited by this paper
• Cohort studies of fat intake and the risk of breast cancer--a pooled analysis.

  1996cited by this paper
• Incidence of p53 and Ha‐ras gene mutations in chemically induced rat mammary carcinomas

  1996cited by this paper
• Stearate inhibition of breast cancer cell proliferation. A mechanism involving epidermal growth factor receptor and G-proteins.

  1996cited by this paper
• Effect of membrane lipid alteration on the growth, phospholipase C activity and G protein of HT-29 tumor cells.

  1996cited by this paper
• Animal models for breast cancer.

  1995cited by this paper
• Stearate inhibits human tumor cell invasion.

  1995cited by this paper
• An essential role for Rac in Ras transformation

  1995cited by this paper
• Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

  1995cited by this paper
• Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation

  1995cited by this paper
• Saturated fatty Acid–Induced Insulin Resistance in Rat Adipocytes

  1994cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• Prognostic factors in early breast carcinoma

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• Nutritional risk factors for breast cancer

  1994cited by this paper
• A meta-analysis of studies of dietary fat and breast cancer risk.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique.

  1992cited by this paper
• The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

  1992cited by this paper
• Small GTP-binding proteins.

  1992cited by this paper
• Cyclins and cancer.

  1991cited by this paper
• Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies.

  1990cited by this paper
• Stearic acid and carcinogenesis.

  1987cited by this paper
• Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin.

  1987cited by this paper
• An improved method for the addition of long-chain free fatty acid to protein solutions.

  1969cited by this paper

• Role of CD25 on resting Treg immune cell in mediating the effect of stearate biosynthesis microbiome pathway on lung adenocarcinoma

  2026cites this paper
• Stearic acid metabolism in human health and disease.

  2024cites this paper
• Association between dietary intake of saturated fatty acid subgroups and breast cancer risk.

  2024cites this paper
• The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy

  2023cites this paper
• Mutant Plant Tipobio Variety of Rodent Tuber (Typhonium Flagelliforme): Fatty Acids Compounds and in Vitro Anticancer Activity

  2023cites this paper
• Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer

  2022cites this paper
• Cytotoxic effect of Cantigi [Vaccinium varingiaefolium (Blume) Miq.] extracts on T47D cells

  2022cites this paper
• Diet, lipids, and antitumor immunity

  2022cites this paper
• Common tumor‐suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells

  2021cites this paper
• Efficacy of pomegranate extract loaded solid lipid nanoparticles transdermal emulgel against Ehrlich ascites carcinoma.

  2021cites this paper
• Stearic acid blunts growth-factor signaling via oleoylation of GNAI proteins

  2021cites this paper
• Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence

  2020influential citation
• PPAR Beta/Delta and the Hallmarks of Cancer

  2020cites this paper
• In vitro Anti-breast cancer and antifungal Bio-efficiency of some microalgal extracts

  2020cites this paper
• Changes in the transcriptome profile of breast cancer cells grown as spheroids.

  2019cites this paper
• Rice

  2019cites this paper
• STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells.

  2019cites this paper
• Evaluation of antitumor activity of leaf extracts from a traditionally used medicinal plant Clerodendrum viscosum Vent

  2017cites this paper
• Relationship between Chinese medicine dietary patterns and the incidence of breast cancer in Chinese women in Hong Kong: a retrospective cross-sectional survey

  2017influential citation
• Antiproliferative and apoptosis inducing activities of leaf organic solvent extract fractions of clerodendrum viscosum vent

  2017cites this paper
• Saturated fatty-acids regulate retinoic acid signaling and suppress tumorigenesis by targeting fatty-acid-binding protein 5

  2015cites this paper
• Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis

  2014cites this paper
• Dietary Stearic Acid Leads to a Reduction of Visceral Adipose Tissue in Athymic Nude Mice

  2014cites this paper
• Exposure to lard-based high-fat diet during fetal and lactation periods modifies breast cancer susceptibility in adulthood in rats.

  2014cites this paper
• The Role of CDK2 and CDK9 in the Radiation Response of human HNSCC Cancer Cells

  2013cites this paper
• Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate.

  2013cites this paper
• ERK-modulated intrinsic signaling and G(2)/M phase arrest contribute to the induction of apoptotic death by allyl isothiocyanate in MDA-MB-468 human breast adenocarcinoma cells.

  2012cites this paper